Metraipolis › archive › dc_669b73e71b24

Improving access to breast cancer screening and treatment in Nigeria: The triple mobile assessment and patient navigation model (NCT05321823): A study protocol — Europe PMC PMID:37310983

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/37310983
DOI
10.1371/journal.pone.0284341
License (as archived)
CC0-1.0
Archived
2026-10-07T12:59:20.721Z
SHA-256 of the archived text
2b14dc7797f0233845445c044ec2b959ae062db3b3f6e7545b9c5f2aefb6e680
Stable URL of this page
https://metraipolis.com/documento/dc_669b73e71b24

How to cite

Improving access to breast cancer screening and treatment in Nigeria: The triple mobile assessment and patient navigation model (NCT05321823): A study protocol — Europe PMC PMID:37310983 — Europe PMC (en), https://europepmc.org/article/MED/37310983 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_669b73e71b24 (Metraipolis archive dc_669b73e71b24, sha256 2b14dc7797f0233845445c044ec2b959ae062db3b3f6e7545b9c5f2aefb6e680)
BibTeX
@misc{dc669b73e71b24,
  title = {Improving access to breast cancer screening and treatment in Nigeria: The triple mobile assessment and patient navigation model (NCT05321823): A study protocol — Europe PMC PMID:37310983},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/37310983},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_669b73e71b24; sha256 2b14dc7797f0233845445c044ec2b959ae062db3b3f6e7545b9c5f2aefb6e680},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/37310983. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Background: In Nigeria, breast cancer incidence is rising, late presentation is common, and outcomes are poor. Patient-related factors such as lack of awareness and misperceptions in addition to health system deficiencies such as lack of a clearly defined framework for breast cancer screening and referral are some of the major drivers of this poor outlook. Guidelines for breast cancer screening in high-income countries have limited applicability in low-middle-income countries, hence the need for innovative, resource-compatible strategies to combat the negative trend. This manuscript presents our study protocol which aims to evaluate the impact of a novel breast cancer early detection program developed to address delayed presentation and lack of access to diagnostic and treatment facilities in South-West Nigeria. This entails the use of mobile technology (innovative handheld iBreast Exam [iBE] device, mobile breast ultrasound, and mobile mammography) and patient navigation as interventions at the community level. Methods: The study (ClinicalTrials.gov identifier: NCT05321823) will adopt a randomized two group clinical trial design with one local government area (LGA) serving as an intervention arm and another serving as the control. Both LGAs will receive breast cancer awareness education but only one will receive the interventions. In the intervention arm, asymptomatic (40-70 years) and symptomatic (30-70 years) women will be invited for breast evaluation which will be performed by trained Community Health Nurses using Clinical Breast Exam (CBE), and iBE. Those with positive findings will proceed to imaging using mobile mammography and ultrasound brought to the LGA every month. Symptomatic women with negative findings on CBE and iBE will be scheduled for repeat clinical evaluation on a short-term basis (one month). The Radiologist will obtain core needle biopsies as indicated and transfer them for prompt pathological assessment. Women presenting to the Primary Healthcare Centers in the control LGA will be referred directly to Obafemi Awolowo University Teaching Hospitals Complex as per the current standard of care. Records of all breast cancer cases seen in the two LGAs during the study period will be obtained. The program metrics will include screening participation rate, cancer detection rate, stage at diagnosis, and timeline from detection to initiation of treatment. The stage at diagnosis and timeline from detection to treatment compared between the two LGAs will be used to assess the impact of the intervention. The study is proposed for 2 years; however, a descriptive analysis will be carried out at 1.5 years to evaluate the retention of the study participants. Study significance: It is anticipated that this study will provide vital data to support wider breast cancer screening efforts in Nigeria.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2023 (prima pubblicazione 2023-06-13).
Identificativi: PMID 37310983 · PMCID PMC10263304 · DOI 10.1371/journal.pone.0284341.
Descrittori MeSH principali: Breast Neoplasms; Patient Navigation.
Pagina: https://europepmc.org/article/MED/37310983 — https://doi.org/10.1371/journal.pone.0284341. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-10-07T12:29:41.947Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.